298 related articles for article (PubMed ID: 16790616)
1. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass.
Maslow AD; Stearns G; Butala P; Schwartz CS; Gough J; Singh AK
Anesth Analg; 2006 Jul; 103(1):2-8, table of contents. PubMed ID: 16790616
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery.
Hasija S; Makhija N; Choudhury M; Hote M; Chauhan S; Kiran U
J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):230-8. PubMed ID: 19875309
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index.
Yamada T; Takeda J; Katori N; Tsuzaki K; Ochiai R
J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598
[TBL] [Abstract][Full Text] [Related]
5. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
[TBL] [Abstract][Full Text] [Related]
6. ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study.
Myles PS; Olenikov I; Bujor MA; Davis BB
Med J Aust; 1993 May; 158(10):675-7. PubMed ID: 8487686
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure and heart rate variability changes during cardiac surgery with cardiopulmonary bypass.
Souza Neto EP; Loufouat J; Saroul C; Paultre C; Chiari P; Lehot JJ; Cerutti C
Fundam Clin Pharmacol; 2004 Jun; 18(3):387-96. PubMed ID: 15147292
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass.
Pretorius M; McFarlane JA; Vaughan DE; Brown NJ; Murphey LJ
Clin Pharmacol Ther; 2004 Oct; 76(4):379-87. PubMed ID: 15470338
[TBL] [Abstract][Full Text] [Related]
9. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
[TBL] [Abstract][Full Text] [Related]
10. The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study.
Shahzamani M; Yousefi Z; Frootaghe AN; Jafarimehr E; Froughi M; Tofighi F; Azadani AN; Pourhoseingholi MA; Azadani PN
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):185-91. PubMed ID: 19721131
[TBL] [Abstract][Full Text] [Related]
11. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
[TBL] [Abstract][Full Text] [Related]
12. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation.
Koelzow H; Gedney JA; Baumann J; Snook NJ; Bellamy MC
Anesth Analg; 2002 Apr; 94(4):824-9, table of contents. PubMed ID: 11916779
[TBL] [Abstract][Full Text] [Related]
13. Methylene blue for refractory hypotension: a case report.
Weissgerber AJ
AANA J; 2008 Aug; 76(4):271-4. PubMed ID: 18777811
[TBL] [Abstract][Full Text] [Related]
14. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY
Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238
[TBL] [Abstract][Full Text] [Related]
15. Deterioration of body oxygen metabolism by vasodilator and/or vasoconstrictor administration during cardiopulmonary bypass.
Sato K; Sogawa M; Namura O; Hayashi J
ASAIO J; 2006; 52(1):96-9. PubMed ID: 16436897
[TBL] [Abstract][Full Text] [Related]
16. Cardio-cerebral and metabolic effects of methylene blue in hypertonic sodium lactate during experimental cardiopulmonary resuscitation.
Miclescu A; Basu S; Wiklund L
Resuscitation; 2007 Oct; 75(1):88-97. PubMed ID: 17482336
[TBL] [Abstract][Full Text] [Related]
17. Effects and arterial concentration of prostaglandin E1 during cardiopulmonary bypass.
Okuda M; Faruhashi K; Konishi K; Muneyuki M
Eur J Anaesthesiol; 1991 Mar; 8(2):129-34. PubMed ID: 1874208
[TBL] [Abstract][Full Text] [Related]
18. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome.
Levin MA; Lin HM; Castillo JG; Adams DH; Reich DL; Fischer GW
Circulation; 2009 Oct; 120(17):1664-71. PubMed ID: 19822810
[TBL] [Abstract][Full Text] [Related]
19. Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review.
McRobb CM; Holt DW
J Extra Corpor Technol; 2008 Sep; 40(3):206-14. PubMed ID: 18853835
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of sevoflurane, isoflurane, and propofol in coronary surgery patients: a randomized controlled study.
Yildirim V; Doganci S; Aydin A; Bolcal C; Demirkilic U; Cosar A
Heart Surg Forum; 2009 Jan; 12(1):E1-9. PubMed ID: 19233758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
